Case T-455/24 R: Order of the President of the General Court of 26 November 2024 – Advanz Pharma v Commission (Interim relief – Medicinal products for human use – Orphan medicinal product for human use Ocaliva – obeticholic acid – Revocation of a conditional marketing authorisation – Application for suspension of operation of a measure – No urgency)